PRA’s Vaccine Solutions group understands the unique challenges and characteristics of vaccine development. Right from the start, our experts will evaluate your clinical program needs and develop the most efficient study strategy.
Succeeding with a Risk-Based Approach
A Phase III double-blind, placebo-controlled study to assess the efficacy, safety, and tolerability of Drug A in patients with moderate to severe…
Overcoming Difficult Recruitment Challenges to Meet Vaccine Study Enrollment Goals
A randomized, observer-blind, placebo-controlled, multi-center, multi-national, Phase III trial evaluating the efficacy, immunogenicity, and safety…
Early Engagement Crucial to Develop Trial Design for Accelerated Schedule Vaccine Study
A case study describing PRA's involvement in an accelerated schedule vaccine study for poliomyelitis.